Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity

B Hervier, H Devilliers, R Stanciu, A Meyer… - Autoimmunity …, 2012 - Elsevier
The clinical phenotype and evolution of antisynthetase syndrome (ASS) are heterogeneous.
This study was therefore undertaken to identify subgroups of ASS patients with similar …

Involvement of NK cells and NKp30 pathway in antisynthetase syndrome

B Hervier, M Perez, Y Allenbach… - The Journal of …, 2016 - journals.aai.org
… The characterization of both T and B cells was … B expression in lung NK cells was shown
by an NKp46 plus granzyme B double staining, using anti-NKp46 and anti–granzyme B (clone …

Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature

C Comarmond, B Crestani, A Tazi, B Hervier… - Medicine, 2014 - journals.lww.com
… Centrilobular and paraseptal emphysema predominating in the upper lobes (B). Ground-glass
opacities in a patchy distribution in nonspecific interstitial pneumonia (C), and reticular …

[HTML][HTML] Erdheim–Chester disease

…, L Arnaud, F Cohen-Aubart, B Hervier… - Current rheumatology …, 2014 - Springer
… Characteristic skeletal abnormalities: a) bilateral and symmetric cortical osteosclerosis of
the diaphyseal and metaphyseal parts of the long bones on X-rays, and/or b) symmetric and …

CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients

L Arnaud, B Hervier, A Néel… - Blood, The Journal …, 2011 - ashpublications.org
Erdheim-Chester disease (ECD) is a rare form of non-Langerhans histiocytosis, with
noncodified therapeutic management and high mortality. No treatment has yet been shown to …

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E …

…, F Charlotte, P Cluzel, A Drier, B Hervier… - Blood, The Journal …, 2013 - ashpublications.org
Histiocytoses are rare disorders of unknown origin with highly heterogeneous prognosis.
BRAF V600E gain-of-function mutations have been observed in 57% of cases of Langerhans …

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

…, Z Hélias-Rodzewicz, B Hervier… - Blood, The Journal …, 2012 - ashpublications.org
Histiocytoses are rare disorders of unknown origin with highly heterogeneous prognosis.
BRAF mutations have been observed in Langerhans cell histiocytosis (LCH). We investigated …

[PDF][PDF] Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF (V600E)-mutated Erdheim-Chester disease

…, F Lifermann, A Idbaih, B Granel, B Graffin, B Hervier… - J Clin Oncol, 2015 - academia.edu
… (A, B) Aortic involvement is characterized by a thickening of the aortic wall, initially described
as … (B) Quantitative assessment by surface of infiltration of descending aorta is shown for …

224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 …

…, I de Groot, M de Visser, H Goebel, B Hervier… - Neuromuscular …, 2018 - Elsevier
… In each of the anti-HMGCR-associated myopathy biopsies, necrosis appeared out of
proportion to the minimal lymphocytic infiltration, suggesting a lesser role of T and B cells in the …

CMV drives clonal expansion of NKG2C+ NK cells expressing self‐specific KIRs in chronic hepatitis patients

…, P Bedossa, A Boudifa, B Hervier… - European journal of …, 2012 - Wiley Online Library
… + CD56 dim NK cells in patients with chronic hepatitis B virus (HBV) or hepatitis C virus (… ,
expressed high amounts of granzyme B and exhibited polyfunctional responses (CD107a, IFN-…